Lerava®

Categories:

Generic name: Leflunomide

Indications:

  • Treatment of active rheumatoid arthritis in adults
  • Lerava® is the first generic form of Leflunomide in Iran which is produced at a GMP approved manufacturing site

Product Sharing:

LinkedIn
Telegram
Facebook
WhatsApp
Email

Product Description:

Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar. Sitagliptin can be taken with or without meal.

Additional Information

Additional information

Related Products

Product Images

lerava-2 lerava-1 lerava